Global Vitreo Retinal Surgery Devices Pipeline Report 2022 Update: Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies - ResearchAndMarkets.com
2022-11-07
并购
DUBLIN--(BUSINESS WIRE)--The "Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
'Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update'
The report enables you to:
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Scope
Extensive coverage of the Vitreo Retinal Surgery Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry
Key Topics Covered:
1 Table of Contents
2 Introduction
3 Products under Development
3.1 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
3.2 Vitreo Retinal Surgery Devices - Pipeline Products by Territory
3.3 Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path
3.4 Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date
3.5 Vitreo Retinal Surgery Devices - Ongoing Clinical Trials
4 Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies
4.1 Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development
5 Vitreo Retinal Surgery Devices Companies and Product Overview
5.1 ABVC BioPharma Inc Company Overview
5.2 AcuSurgical Company Overview
5.3 Alcon Inc Company Overview
5.4 Bausch & Lomb Inc Company Overview
5.5 Beaver-Visitec International Inc Company Overview
5.6 Boston College Company Overview
5.7 Cambridge Polymer Group Inc Company Overview
5.8 Carnegie Mellon University Company Overview
5.9 Duke University Company Overview
5.10 Dutch Ophthalmic Research Center International BV Company Overview
5.11 Johns Hopkins University Company Overview
5.12 King's College London Company Overview
5.13 Medisse BV (Inactive) Company Overview
5.14 RetinaSense Company Overview
5.15 Synergetics USA, Inc. (Inactive) Company Overview
5.16 The Chinese University of Hong Kong Company Overview
5.17 University of Kansas Company Overview
5.18 University of Minnesota Company Overview
6 Vitreo Retinal Surgery Devices- Recent Developments
7 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/zd122m
Source: GlobalData
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。